Clinical trial
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female…
NCT00171470 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171470 |
|---|---|
| Title | The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. |
| Official title | The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyspepsia |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 1, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: